SCOPUS 정보 검색 플랫폼

Volumn 18, Issue 5, 2009, Pages 387-392

The comparative study on supervision and incentive policies of Sino-US during the innovative drug R&D

a CHINA PHARMACEUTICAL UNIVERSITY (China)

Author keywords

Comparative study; Control and incentive policies; Innovative drug R D

Indexed keywords

ARTICLE; CHINA; COMPARATIVE STUDY; COMPETITIVE BEHAVIOR; DRUG CONTROL; DRUG DEVELOPMENT; DRUG RESEARCH; ECONOMIC ASPECT; ECONOMIC DEVELOPMENT; HEALTH CARE POLICY; HUMAN; PHARMACEUTICS; SOCIAL ASPECT; UNITED STATES;

EID: 77954845881 PISSN: 10033734 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (5)

References (25)

1
- 0032213416
- Innovation deficit revisited: Reflections on the productivity of pharmaceutical R&D
- J
- DREWS J. Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D [J]. Drug Discov Today, 1998, 3(11):491-494.
- (1998) Drug Discov Today , vol.3 , Issue.11 , pp. 491-494
- Drews, J.¹

2
- 77954849140
- Chinese source

3
- 77954838308
- Chinese source

4
- 77954858284
- Chinese source

5
- 77954853503
- Chinese source

6
- 77954849398
- Chinese source

7
- 77954854599
- Chinese source

8
- 77954839769
- Chinese source

9
- 77954851319
- Chinese source

10
- 77954857224
- Chinese source

11
- 77954843141
- Chinese source

12
- 77954851585
- Chinese source

13
- 77954842980
- Chinese source

14
- 77954855063
- Chinese source

15
- 77954852981
- Chinese source

16
- 26144463252
- HHS · OFFICE OF INSPECTOR GENERAL: -5-31
- HHS · OFFICE OF INSPECTOR GENERAL: The Orphan Drug Act-Implementation and Impact[EB/OL]. (2001-5-31). http://www.fda.gov.
- (2001) The Orphan Drug Act-Implementation and Impact[EB/OL]

17
- 77954845724
- Chinese source

18
- 77954839239
- Chinese source

19
- 77954852417
- CDER: 03-20
- FDA · CDER: Frequently asked questions on Prescription Drug User Fees (PDUFA) [EB/OL]. (2008-03-20). http://www.fda.gov/cder.
- (2008) Frequently Asked Questions on Prescription Drug User Fees (PDUFA) [EB/OL]

20
- 77954847199
- Chinese source

21
- 77954840377
- Chinese source

22
- 0032799186
- Overview of the Hatch-Waxman Act and its impact on the drug development process
- J
- GERALD J, MOSSINGHOFF. Overview of the Hatch-Waxman Act and its impact on the drug development process [J]. Food Drug Law J, 1999, 54(2):187-194.
- (1999) Food Drug Law J , vol.54 , Issue.2 , pp. 187-194
- Gerald, J.¹ Mossinghoff²

23
- 77954841404
- Chinese source

24
- 77954836413
- Chinese source

25
- 34547869291
- The influence of market exclusivity on drug availability and medical innovations
- J
- GLOVER GJ. The influence of market exclusivity on drug availability and medical innovations [J]. AAPS J, 2007 ,9(3):E312-E316.
- (2007) AAPS J , vol.9 , Issue.3
- Glover, G.J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.